ZIMVIE INC (ZIMV)
US98888T1079 - Common Stock
We assign a fundamental rating of 2 out of 10 to ZIMV. ZIMV was compared to 187 industry peers in the Health Care Equipment & Supplies industry. ZIMV has a bad profitability rating. Also its financial health evaluation is rather negative. ZIMV has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year ZIMV was profitable.
ZIMV had a positive operating cash flow in the past year.
ZIMV had negative earnings in each of the past 5 years.
ZIMV had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ZIMV has a Return On Assets of -52.03%. This is in the lower half of the industry: ZIMV underperforms 67.38% of its industry peers.
ZIMV has a worse Return On Equity (-100.17%) than 63.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -52.03% | ||
| ROE | -100.17% | ||
| ROIC | N/A |
ROA(3y)-13.91%
ROA(5y)-10.45%
ROE(3y)-37.01%
ROE(5y)-24.95%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ZIMV has a better Gross Margin (63.47%) than 64.71% of its industry peers.
ZIMV's Gross Margin has been stable in the last couple of years.
ZIMV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 63.47% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.14%
GM growth 5Y-0.53%
2. Health
2.1 Basic Checks
ZIMV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZIMV has more shares outstanding
ZIMV has a worse debt/assets ratio than last year.
2.2 Solvency
ZIMV has an Altman-Z score of 0.93. This is a bad value and indicates that ZIMV is not financially healthy and even has some risk of bankruptcy.
ZIMV's Altman-Z score of 0.93 is in line compared to the rest of the industry. ZIMV outperforms 46.52% of its industry peers.
The Debt to FCF ratio of ZIMV is 29.84, which is on the high side as it means it would take ZIMV, 29.84 years of fcf income to pay off all of its debts.
ZIMV's Debt to FCF ratio of 29.84 is fine compared to the rest of the industry. ZIMV outperforms 68.45% of its industry peers.
ZIMV has a Debt/Equity ratio of 0.54. This is a neutral value indicating ZIMV is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.54, ZIMV is not doing good in the industry: 64.17% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.54 | ||
| Debt/FCF | 29.84 | ||
| Altman-Z | 0.93 |
ROIC/WACCN/A
WACC9.19%
2.3 Liquidity
A Current Ratio of 1.94 indicates that ZIMV should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.94, ZIMV is doing worse than 68.45% of the companies in the same industry.
A Quick Ratio of 1.38 indicates that ZIMV should not have too much problems paying its short term obligations.
ZIMV's Quick ratio of 1.38 is on the low side compared to the rest of the industry. ZIMV is outperformed by 65.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
The earnings per share for ZIMV have decreased strongly by -34.85% in the last year.
ZIMV shows a decrease in Revenue. In the last year, the revenue decreased by -9.82%.
The Revenue for ZIMV have been decreasing by -16.08% on average. This is quite bad
EPS 1Y (TTM)-34.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)-9.82%
Revenue growth 3Y-20.56%
Revenue growth 5Y-16.08%
Sales Q2Q%-49.12%
3.2 Future
Based on estimates for the next years, ZIMV will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.93% on average per year.
Based on estimates for the next years, ZIMV will show a very negative growth in Revenue. The Revenue will decrease by -18.81% on average per year.
EPS Next Y0.05%
EPS Next 2Y12.27%
EPS Next 3Y13.93%
EPS Next 5YN/A
Revenue Next Year-47.88%
Revenue Next 2Y-27.42%
Revenue Next 3Y-18.81%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 31.63, which means the current valuation is very expensive for ZIMV.
Based on the Price/Earnings ratio, ZIMV is valued a bit cheaper than 72.19% of the companies in the same industry.
When comparing the Price/Earnings ratio of ZIMV to the average of the S&P500 Index (27.73), we can say ZIMV is valued inline with the index average.
The Price/Forward Earnings ratio is 17.98, which indicates a rather expensive current valuation of ZIMV.
ZIMV's Price/Forward Earnings ratio is rather cheap when compared to the industry. ZIMV is cheaper than 85.03% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ZIMV to the average of the S&P500 Index (22.83), we can say ZIMV is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.63 | ||
| Fwd PE | 17.98 |
4.2 Price Multiples
ZIMV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ZIMV is cheaper than 86.10% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ZIMV is valued a bit cheaper than 75.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.85 | ||
| EV/EBITDA | 14.12 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZIMV does not grow enough to justify the current Price/Earnings ratio.
ZIMV's earnings are expected to grow with 13.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)702.84
PEG (5Y)N/A
EPS Next 2Y12.27%
EPS Next 3Y13.93%
5. Dividend
5.1 Amount
No dividends for ZIMV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ZIMVIE INC
NASDAQ:ZIMV (12/20/2024, 8:00:02 PM)
After market: 13.6 0 (0%)13.6
+0.08 (+0.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners91.66%
Inst Owner Change1.14%
Ins Owners2.11%
Ins Owner Change-0.21%
Market Cap375.36M
Analysts77.78
Price Target20.78 (52.79%)
Short Float %1.1%
Short Ratio2.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)26.18%
Min EPS beat(2)-25.9%
Max EPS beat(2)78.25%
EPS beat(4)2
Avg EPS beat(4)81.72%
Min EPS beat(4)-25.9%
Max EPS beat(4)296.08%
EPS beat(8)5
Avg EPS beat(8)212.06%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.13%
Min Revenue beat(2)-0.2%
Max Revenue beat(2)-0.07%
Revenue beat(4)0
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)-0.07%
Revenue beat(8)3
Avg Revenue beat(8)0.4%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)4.44%
EPS NQ rev (3m)19.35%
EPS NY rev (1m)1.99%
EPS NY rev (3m)1.9%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-1.65%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.63 | ||
| Fwd PE | 17.98 | ||
| P/S | 0.47 | ||
| P/FCF | 50.85 | ||
| P/OCF | 26.47 | ||
| P/B | 0.92 | ||
| P/tB | 8.23 | ||
| EV/EBITDA | 14.12 |
EPS(TTM)0.43
EY3.16%
EPS(NY)0.76
Fwd EY5.56%
FCF(TTM)0.27
FCFY1.97%
OCF(TTM)0.51
OCFY3.78%
SpS28.83
BVpS14.73
TBVpS1.65
PEG (NY)702.84
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -52.03% | ||
| ROE | -100.17% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 63.47% | ||
| FCFM | 0.93% |
ROA(3y)-13.91%
ROA(5y)-10.45%
ROE(3y)-37.01%
ROE(5y)-24.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.14%
GM growth 5Y-0.53%
F-Score4
Asset Turnover1.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.54 | ||
| Debt/FCF | 29.84 | ||
| Debt/EBITDA | 5.91 | ||
| Cap/Depr | 13% | ||
| Cap/Sales | 0.85% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 38.02% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 0.93 |
F-Score4
WACC9.19%
ROIC/WACCN/A
Cap/Depr(3y)25.16%
Cap/Depr(5y)28.65%
Cap/Sales(3y)3.74%
Cap/Sales(5y)4.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y0.05%
EPS Next 2Y12.27%
EPS Next 3Y13.93%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.82%
Revenue growth 3Y-20.56%
Revenue growth 5Y-16.08%
Sales Q2Q%-49.12%
Revenue Next Year-47.88%
Revenue Next 2Y-27.42%
Revenue Next 3Y-18.81%
Revenue Next 5YN/A
EBIT growth 1Y69.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-1.47%
EBIT Next 3Y10.14%
EBIT Next 5YN/A
FCF growth 1Y-35.13%
FCF growth 3Y-19.74%
FCF growth 5Y-26.34%
OCF growth 1Y-74.18%
OCF growth 3Y-24.41%
OCF growth 5Y-25.51%